Cancer survivor's kidney saves son's life
The procedure saved the young man from undergoing regular dialysis.
The 37-year-old recipient, Yedla Lakshmanudu said: 'We are from Pithapuram. Six months ago, I had vomiting twice and was taken to a hospital in our town. I was diagnosed with kidney disease and was on dialysis for two months. Subsequently, I was referred to AINU and came here. The doctors informed me that I had to undergo kidney transplant. My father, Yedla Paidiyya, despite having undergone cancer treatment in the past, agreed to donate his kidney. After the surgery, I was kept under observation for eight days. I am fine now and back to my routine chores. My father is also fine.'
Dr. Uday Dipakrao Gajare, consultant nephrologist, AINU, said that Alport syndrome affects one or two individuals per lakh . The disorder affects kidney function, hearing and vision. In Lakshmanudu's case only the kidneys were affected. The X-linked variant found in Lakshmanudu is typically passed on from mother to son, with daughters being carriers.
Dr. G. Ravindra Varma, senior consultant urologist, transplant surgeon, and MD of the hospital, said removal of one of the two kidneys does not affect a healthy donor's day-to-day functioning. Kidney transplant from live, and related donor is more successful than a cadaver transplant. Hence, when live blood relations with matching group are available, it was always better to go for live donors.
Dr. Amit Saple, senior consultant urologist, transplant surgeon and executive director of the hospital, also addressed the media.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
11-08-2025
- The Hindu
AINU launches new centre in Hyderabad covering various sub-specialities
The Asian Institute of Nephrology and Urology (AINU), launched its new centre in Banjara Hills here on Monday. The hospital has a capacity of 150 beds. The centre features four operating rooms, 34 dialysis stations and advanced robotic surgical technology, enabling complex urology and nephrology procedures with greater precision. The hospital also has eight centres of excellence, covering sub-specialities such as female urology, uro-oncology and robotic surgery, paediatric urology, reconstructive urology and andrology. The burden of urological diseases is rising sharply in India due to lifestyle disorders such as hypertension, obesity and diabetes, coupled with increased life expectancy. 'Prostate cancer is now the second most common cancer among Indian men, growing at 2.5% annually, and 50 to 60% of men over 60 suffer from benign prostatic enlargement,' said AINU manging director Mallikarjuna. He added that 25 years ago, urology was largely limited to treating kidney stones and enlarged prostates. Today, the scope includes advanced cancer care, complex reconstructions, paediatric interventions, female urology and robotic surgeries. 'One doctor cannot be perfect in every area, so we have created dedicated teams focused solely on one sub-speciality, performing the same surgeries repeatedly. This results in faster procedures, fewer complications, better outcomes and ultimately lower costs for patients,' he added.
Time of India
11-08-2025
- Time of India
Asia Healthcare Holdings to invest Rs 400 crore in Asian Institute of Nephrology and Urology to double hospital network
Asia Healthcare Holdings , a leading healthcare investment platform backed by Singapore's GIC and TPG, will invest Rs 400 crore in Asian Institute of Nephrology and Urology (AINU), one of the largest single-speciality chains focused on uro-nephro care, in the next 4-5 years, AHH's executive chairman Vishal Bali told ET. AHH, which has currently over 70% stake in AINU, will invest this fund for growth and expansion of the urology and nephrology chain with plans to open 13 hospitals from current seven in the next 3-4 years – with most planned in Tier 2 towns such as Patna, Bhubaneshwar, Coimbatore, and others. Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program The planned outlay of Rs 400 crore will take AHH's full investment in the chain to Rs 1,000 crore since FY24, making it one of the largest investments in the single-speciality format in the urology-nephrology space. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 'Rs 600 crore of our capital is in AINU and there is another Rs 400 crore outlay between now and FY30. That makes a total of Rs 1,000 crore investment that we will put behind this specialty,' said Bali. 'We will invest the fund in the growth creation of a much bigger footprint for AINU,' he added. 'We see a big opportunity at AHH in the creation and exponential growth of single specialty enterprises in the Tier 2 cities,' said Bali. Live Events Currently, AINU is present in seven locations including two Metro cities in Hyderabad and Chennai. All its other hospitals are in Tier 2 cities including places like Vizag and Siliguri. While its flagship centre in Hyderabad has 150 beds capacity, Chennai has 100 beds and the others in tier 2 are mostly 75 bedders. 'We are looking to ramp up the clinical capabilities and services in each of these hospitals. Robotic programme is an important service that we have – currently we have two centres offering this service – we want to start ramping it up in other centres,' said Sandeep Guduru, CEO, AINU. 'In our new centre in Banjara Hills in Hyderabad the focus is on setting up sub-specialities such as female neurology, paediatric neurology, etc. That's also a large part of our growth capex,' said Guduru. For FY 26-27, AHH has earmarked an outlay of Rs 150 crore capital expenditure in AINU to open 3-4 new urology and nephrology hospitals across India. India's market for single-specialty hospitals is set to more-than-double to $31 billion in three-four years from the current $15 billion. Most of it is private equity-led expansion into small towns and hinterlands where demand for quality healthcare services is growing rapidly, according to a report from investment bank Avendus. 'There are certain specialties that have come out of the multispecialty format and created a growth trajectory of their own,' said Bali. Explaining the fund's investment strategy, he said 'We are gung-ho about single specialty as it gives us the opportunity to scale quickly, our return on capital employed (ROCE) are much higher than what the multispecialty institutions see. From an India context this format will work very well because there is a replication opportunity.' The market share of single specialty hospitals, catering to segments like eyecare, oncology, fertility treatments and mother & child-care, urology and nephrology and dental care is expected to rise to 40% of the total healthcare market by 2028 from the current 30%, according to Avendus.
&w=3840&q=100)
Business Standard
11-08-2025
- Business Standard
GIC, TPG-backed AHH targets 20 AINU hospitals by FY30, eyes GI entry
Asian Healthcare Holdings (AHH), backed by Singapore sovereign wealth fund GIC and private equity firm TPG, plans to expand to about 20 nephrology and urology facilities under its Asian Institute of Nephrology and Urology (AINU) brand by the end of FY30. AINU currently operates over 500 beds in seven hospitals across Hyderabad, Visakhapatnam, Siliguri, and Chennai. It inaugurated a 200-bed flagship hospital in Hyderabad on Monday. 'Between FY26 and FY27, there will be another three to four hospitals, which will take our tally to 12-13 facilities,' Vishal Bali, executive chairman of AHH, told Business Standard. With this expansion, AINU's bed capacity will reach about 850. He added that the next phase of growth will focus on tier-II cities such as Bhubaneswar, Patna, Coimbatore, and Pune. Sandeep Guduru, chief executive officer of AINU, said Rs 150 crore in capital expenditure has been earmarked to open three to four new urology and nephrology facilities in the next 12 months. 'We are also expanding our robotic surgery capabilities in a couple of our other cities,' he added. Bali said that between FY27 and FY30, AINU could add another seven to eight hospitals, taking the total to around 20. AHH, which owns Motherhood Hospitals (maternity care), AINU, and Nova IVF (IVF), is a healthcare platform specialising in single-specialty hospitals. The network now plans to enter one or two additional specialties. 'Gastroenterology (GI) is one such specialty that we would be keen to explore,' Bali said. He explained that GI offers a strong outpatient department with endoscopy, as well as inpatient procedures largely driven by minimal access surgery. On the possibility of an initial public offering, Bali declined to share a timeline, saying it was a matter of when the investors deemed it appropriate. 'However, with the Ebitda that we have on the platform today, the company could potentially go to an IPO even in the next 16 or 18 months,' he said.
